Structurally, they look similar: MNK1 and MNK2 belong to the same enzyme family and are best known for regulating how cells ...

Study reveals that reversible chemical modifications can inhibit pyruvate kinase and affect its variants differently, ...

Pramorelin, also known in scientific literature as a synthetic ghrelin receptor agonist, has emerged as a notable peptide within the broader landscape of endocrine and metabolic research. Its primary ...

A new study reveals that the twin enzymes MNK1 and MNK2 play distinct roles in the brain, with one governing memory and the other social behavior.

Executives from Nurix Therapeutics (NASDAQ:NRIX) used a recent discussion on the company’s immunology and inflammation (I&I) ...

Researchers at the Max Delbrück Center show that two related enzymes, MNK1 and MNK2, act on the brain to regulate different behaviors. Their findings, published in "Molecular Psychiatry," could help ...

This review examines how GLP-1 receptor agonists may influence neurodegenerative disease biology through metabolic, ...

Nimbus Therapeutics, LLC ("Nimbus Therapeutics" or "Nimbus"), a drug discovery company developing breakthrough medicines ...

Del-desiran reduced DMPK mRNA levels, but led to two serious adverse events ...

HepaRegeniX GmbH (“HepaRegeniX”), a clinical-stage biotech company advancing novel therapies for acute and chronic liver diseases, today announced the completion of the Phase Ib minor resection study ...